Implications of tioguanine dosing in IBD patients with a TPMT deficiency
Debbie S. Deben, Dennis R. Wong(Zuyderland Medisch Centrum), B.J.C. van den Bosch(Maastricht University Medical Centre), Adriaan A. van Bodegraven(Zuyderland Medisch Centrum), Luc J. J. Derijks(Radboud University Nijmegen), Rob H. Creemers(Zuyderland Medisch Centrum), A. Van Nunen(Zuyderland Medisch Centrum)
Cited by 0
Related Papers
Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease
|Gastroenterology|2015|199
Dose-Dependent Influence of 5-Aminosalicylates on Thiopurine Metabolism
|The American Journal of Gastroenterology|2007|101
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study
|Journal of Crohn s and Colitis|2020|71